A newly converted office campus along the San Francisco waterfront has landed its first biotech tenant, a sign that while demand for lab real estate has softened, companies are still willing to invest in upgrading their spaces.
A newly converted office campus along the San Francisco waterfront has landed its first biotech tenant, a sign that while demand for lab real estate has softened, companies are still willing to invest in upgrading their spaces.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate